Drug Repositioning Service - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511241723

Publication Date:

November 28, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
The global market for Drug Repositioning Service was estimated to be worth US$ 26270 million in 2023 and is forecast to a readjusted size of US$ 36480 million by 2030 with a CAGR of 4.7% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Repositioning Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Repositioning Service by region & country, by Type, and by Application.
The Drug Repositioning Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repositioning Service.
麻豆原创 Segmentation
By Company
Biovista
Anaxomics Biotech
Segue Therapeutics
GVK Biosciences
LTT Bio-Pharma
Segment by Type:
Generic Drugs
Clinical Trial Failed Drugs
Segment by Application
Cardiovascular Diseases
Mental Illness
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Repositioning Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Repositioning Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Repositioning Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Drug Repositioning Service Product Introduction
1.2 Global Drug Repositioning Service 麻豆原创 Size Forecast
1.3 Drug Repositioning Service 麻豆原创 Trends & Drivers
1.3.1 Drug Repositioning Service Industry Trends
1.3.2 Drug Repositioning Service 麻豆原创 Drivers & Opportunity
1.3.3 Drug Repositioning Service 麻豆原创 Challenges
1.3.4 Drug Repositioning Service 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Repositioning Service Players Revenue Ranking (2023)
2.2 Global Drug Repositioning Service Revenue by Company (2019-2024)
2.3 Key Companies Drug Repositioning Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug Repositioning Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug Repositioning Service
2.6 Drug Repositioning Service 麻豆原创 Competitive Analysis
2.6.1 Drug Repositioning Service 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug Repositioning Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Generic Drugs
3.1.2 Clinical Trial Failed Drugs
3.2 Global Drug Repositioning Service Sales Value by Type
3.2.1 Global Drug Repositioning Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Repositioning Service Sales Value, by Type (2019-2030)
3.2.3 Global Drug Repositioning Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cardiovascular Diseases
4.1.2 Mental Illness
4.1.3 Cancer
4.1.4 Other
4.2 Global Drug Repositioning Service Sales Value by Application
4.2.1 Global Drug Repositioning Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Repositioning Service Sales Value, by Application (2019-2030)
4.2.3 Global Drug Repositioning Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug Repositioning Service Sales Value by Region
5.1.1 Global Drug Repositioning Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Repositioning Service Sales Value by Region (2019-2024)
5.1.3 Global Drug Repositioning Service Sales Value by Region (2025-2030)
5.1.4 Global Drug Repositioning Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug Repositioning Service Sales Value, 2019-2030
5.2.2 North America Drug Repositioning Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug Repositioning Service Sales Value, 2019-2030
5.3.2 Europe Drug Repositioning Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug Repositioning Service Sales Value, 2019-2030
5.4.2 Asia Pacific Drug Repositioning Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug Repositioning Service Sales Value, 2019-2030
5.5.2 South America Drug Repositioning Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug Repositioning Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug Repositioning Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Repositioning Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Repositioning Service Sales Value
6.3 United States
6.3.1 United States Drug Repositioning Service Sales Value, 2019-2030
6.3.2 United States Drug Repositioning Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Repositioning Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Repositioning Service Sales Value, 2019-2030
6.4.2 Europe Drug Repositioning Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Repositioning Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Repositioning Service Sales Value, 2019-2030
6.5.2 China Drug Repositioning Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Repositioning Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Repositioning Service Sales Value, 2019-2030
6.6.2 Japan Drug Repositioning Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Repositioning Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Repositioning Service Sales Value, 2019-2030
6.7.2 South Korea Drug Repositioning Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Repositioning Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Repositioning Service Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Repositioning Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Repositioning Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Repositioning Service Sales Value, 2019-2030
6.9.2 India Drug Repositioning Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Repositioning Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biovista
7.1.1 Biovista Profile
7.1.2 Biovista Main Business
7.1.3 Biovista Drug Repositioning Service Products, Services and Solutions
7.1.4 Biovista Drug Repositioning Service Revenue (US$ Million) & (2019-2024)
7.1.5 Biovista Recent Developments
7.2 Anaxomics Biotech
7.2.1 Anaxomics Biotech Profile
7.2.2 Anaxomics Biotech Main Business
7.2.3 Anaxomics Biotech Drug Repositioning Service Products, Services and Solutions
7.2.4 Anaxomics Biotech Drug Repositioning Service Revenue (US$ Million) & (2019-2024)
7.2.5 Anaxomics Biotech Recent Developments
7.3 Segue Therapeutics
7.3.1 Segue Therapeutics Profile
7.3.2 Segue Therapeutics Main Business
7.3.3 Segue Therapeutics Drug Repositioning Service Products, Services and Solutions
7.3.4 Segue Therapeutics Drug Repositioning Service Revenue (US$ Million) & (2019-2024)
7.3.5 GVK Biosciences Recent Developments
7.4 GVK Biosciences
7.4.1 GVK Biosciences Profile
7.4.2 GVK Biosciences Main Business
7.4.3 GVK Biosciences Drug Repositioning Service Products, Services and Solutions
7.4.4 GVK Biosciences Drug Repositioning Service Revenue (US$ Million) & (2019-2024)
7.4.5 GVK Biosciences Recent Developments
7.5 LTT Bio-Pharma
7.5.1 LTT Bio-Pharma Profile
7.5.2 LTT Bio-Pharma Main Business
7.5.3 LTT Bio-Pharma Drug Repositioning Service Products, Services and Solutions
7.5.4 LTT Bio-Pharma Drug Repositioning Service Revenue (US$ Million) & (2019-2024)
7.5.5 LTT Bio-Pharma Recent Developments
8 Industry Chain Analysis
8.1 Drug Repositioning Service Industrial Chain
8.2 Drug Repositioning Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Repositioning Service Sales Model
8.5.2 Sales Channel
8.5.3 Drug Repositioning Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Biovista
Anaxomics Biotech
Segue Therapeutics
GVK Biosciences
LTT Bio-Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.